93 related articles for article (PubMed ID: 18177905)
1. Serotonin transporter binding and acquired obesity -- an imaging study of monozygotic twin pairs.
Koskela AK; Kaurijoki S; Pietiläinen KH; Karhunen L; Pesonen U; Kuikka JT; Kaprio J; Rissanen A
Physiol Behav; 2008 Mar; 93(4-5):724-32. PubMed ID: 18177905
[TBL] [Abstract][Full Text] [Related]
2. Serotonin transporter binding of [123I]ADAM in bulimic women, their healthy twin sisters, and healthy women: a SPET study.
Koskela AK; Keski-Rahkonen A; Sihvola E; Kauppinen T; Kaprio J; Ahonen A; Rissanen A
BMC Psychiatry; 2007 May; 7():19. PubMed ID: 17511889
[TBL] [Abstract][Full Text] [Related]
3. Association of central serotonin transporter availability and body mass index in healthy Europeans.
Hesse S; van de Giessen E; Zientek F; Petroff D; Winter K; Dickson JC; Tossici-Bolt L; Sera T; Asenbaum S; Darcourt J; Akdemir UO; Knudsen GM; Nobili F; Pagani M; Vander Borght T; Van Laere K; Varrone A; Tatsch K; Sabri O; Booij J
Eur Neuropsychopharmacol; 2014 Aug; 24(8):1240-7. PubMed ID: 24976619
[TBL] [Abstract][Full Text] [Related]
4. [123I]-beta-CIT SPECT imaging shows reduced thalamus-hypothalamus serotonin transporter availability in 24 drug-free obsessive-compulsive checkers.
Zitterl W; Aigner M; Stompe T; Zitterl-Eglseer K; Gutierrez-Lobos K; Schmidl-Mohl B; Wenzel T; Demal U; Zettinig G; Hornik K; Thau K
Neuropsychopharmacology; 2007 Aug; 32(8):1661-8. PubMed ID: 17192774
[TBL] [Abstract][Full Text] [Related]
5. Serotonin Transporter Binding in the Diencephalon Is Reduced in Insulin-Resistant Obese Humans.
Versteeg RI; Koopman KE; Booij J; Ackermans MT; Unmehopa UA; Fliers E; la Fleur SE; Serlie MJ
Neuroendocrinology; 2017; 105(2):141-149. PubMed ID: 27626923
[TBL] [Abstract][Full Text] [Related]
6. Cerebral serotonin transporter binding is inversely related to body mass index.
Erritzoe D; Frokjaer VG; Haahr MT; Kalbitzer J; Svarer C; Holst KK; Hansen DL; Jernigan TL; Lehel S; Knudsen GM
Neuroimage; 2010 Aug; 52(1):284-9. PubMed ID: 20382236
[TBL] [Abstract][Full Text] [Related]
7. Neither cortisol nor brain-derived neurotrophic factor is associated with serotonin transporter in bipolar disorder.
Chou YH; Lirng JF; Hsieh WC; Chiu YC; Tu YA; Wang SJ
Eur Neuropsychopharmacol; 2016 Feb; 26(2):280-287. PubMed ID: 26706694
[TBL] [Abstract][Full Text] [Related]
8. Chorea-acanthocytosis in monozygotic twins: clinical findings and neuropathological changes as detected by diffusion tensor imaging, FDG-PET and (123)I-beta-CIT-SPECT.
Müller-Vahl KR; Berding G; Emrich HM; Peschel T
J Neurol; 2007 Aug; 254(8):1081-8. PubMed ID: 17294064
[TBL] [Abstract][Full Text] [Related]
9. Brain serotonin transporter binding of [123I]ADAM: within-subject variation between summer and winter data.
Koskela A; Kauppinen T; Keski-Rahkonen A; Sihvola E; Kaprio J; Rissanen A; Ahonen A
Chronobiol Int; 2008 Sep; 25(5):657-65. PubMed ID: 18780196
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Obesity on the Availabilities of Dopamine and Serotonin Transporters.
Nam SB; Kim K; Kim BS; Im HJ; Lee SH; Kim SJ; Kim IJ; Pak K
Sci Rep; 2018 Mar; 8(1):4924. PubMed ID: 29563547
[TBL] [Abstract][Full Text] [Related]
11. Serotonin transporter binding with [123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender.
Ruhé HG; Booij J; Reitsma JB; Schene AH
Eur J Nucl Med Mol Imaging; 2009 May; 36(5):841-9. PubMed ID: 19183998
[TBL] [Abstract][Full Text] [Related]
12. Validity of [123I]beta-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity.
Reneman L; Booij J; Habraken JB; De Bruin K; Hatzidimitriou G; Den Heeten GJ; Ricaurte GA
Synapse; 2002 Dec; 46(3):199-205. PubMed ID: 12325046
[TBL] [Abstract][Full Text] [Related]
13. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
Pirker W; Asenbaum S; Hauk M; Kandlhofer S; Tauscher J; Willeit M; Neumeister A; Praschak-Rieder N; Angelberger P; Brücke T
J Nucl Med; 2000 Jan; 41(1):36-44. PubMed ID: 10647603
[TBL] [Abstract][Full Text] [Related]
14. Serotonin transporter and dopamine transporter imaging in the canine brain.
Peremans K; Goethals I; De Vos F; Dobbeleir A; Ham H; Van Bree H; Van Heeringen C; Audenaert K
Nucl Med Biol; 2006 Oct; 33(7):907-13. PubMed ID: 17045171
[TBL] [Abstract][Full Text] [Related]
15. Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography study.
Hesse S; Rullmann M; Luthardt J; Winter K; Hankir MK; Becker GA; Zientek F; Reissig G; Regenthal R; Drabe M; Schinke C; Bresch A; Arelin K; Lobsien D; Patt M; Meyer PM; Fasshauer M; Fenske WK; Blüher M; Stumvoll M; Sabri O
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1096-104. PubMed ID: 26577939
[TBL] [Abstract][Full Text] [Related]
16. Comparison of brain serotonin transporter using [I-123]-ADAM between obese and non-obese young adults without an eating disorder.
Wu CH; Chang CS; Yang YK; Shen LH; Yao WJ
PLoS One; 2017; 12(2):e0170886. PubMed ID: 28182708
[TBL] [Abstract][Full Text] [Related]
17. Reduced midbrain serotonin transporter availability in drug-naïve patients with depression measured by SERT-specific [(123)I] nor-beta-CIT SPECT imaging.
Joensuu M; Tolmunen T; Saarinen PI; Tiihonen J; Kuikka J; Ahola P; Vanninen R; Lehtonen J
Psychiatry Res; 2007 Feb; 154(2):125-31. PubMed ID: 17289353
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.
Staley JK; Krishnan-Sarin S; Zoghbi S; Tamagnan G; Fujita M; Seibyl JP; Maciejewski PK; O'Malley S; Innis RB
Synapse; 2001 Sep; 41(4):275-84. PubMed ID: 11494398
[TBL] [Abstract][Full Text] [Related]
19. Brain SPECT imaging and whole-body biodistribution with [(123)I]ADAM - a serotonin transporter radiotracer in healthy human subjects.
Lin KJ; Liu CY; Wey SP; Hsiao IT; Wu J; Fu YK; Yen TC
Nucl Med Biol; 2006 Feb; 33(2):193-202. PubMed ID: 16546673
[TBL] [Abstract][Full Text] [Related]
20. Reduced midbrain-pons serotonin transporter binding in patients with obsessive-compulsive disorder.
Hasselbalch SG; Hansen ES; Jakobsen TB; Pinborg LH; Lønborg JH; Bolwig TG
Acta Psychiatr Scand; 2007 May; 115(5):388-94. PubMed ID: 17430417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
